{
    "Trade/Device Name(s)": [
        "AMICUS Separator System"
    ],
    "Submitter Information": "Fresenius Kabi USA, LLC",
    "510(k) Number": "K162462",
    "Predicate Device Reference 510(k) Number(s)": [
        "K141019",
        "BK150357"
    ],
    "Regulatory Class": "",
    "Product Code(s)": [
        "LKN",
        "GKT"
    ],
    "Summary Letter Date": "November 23, 2016",
    "Summary Letter Received Date": "September 2, 2016",
    "Submission Date": "September 1, 2016",
    "Regulation Number(s)": [
        "21 CFR 864.9245"
    ],
    "Regulation Name(s)": [
        "Automated Blood Cell Separator"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Platelets",
        "Red Blood Cells",
        "Mononuclear Cells",
        "Plasma",
        "Clotting factors"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "AMICUS apheresis kit",
        "AMICUS platelet storage container"
    ],
    "Instrument(s)/Platform(s)": [
        "AMICUS Separator System"
    ],
    "Method(s)/Technology(ies)": [
        "Continuous-flow centrifugal separation"
    ],
    "Methodologies": [
        "Apheresis",
        "Cell separation",
        "Automated collection"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "System",
        "Kit",
        "Software",
        "Container"
    ],
    "Document Summary": "FDA 510(k) summary for the AMICUS Separator System modified with software 5.1 for automated blood cell and plasma separation/collection using centrifugal apheresis",
    "Indications for Use Summary": "Automated blood cell separator indicated for therapeutic plasma exchange and for collection of blood components (platelets, red blood cells, plasma, mononuclear cells) by apheresis, maintaining safe extracorporeal volume and post-donation platelet count",
    "fda_folder": "Hematology"
}